Proxisense develops novel sensor technologies and is advancing applications in Pharmaceutical Process Analysis and Medical Diagnostics. The company originated from Oxford University and has aerospace beginnings. Proxisense says large pharma partners are already working with prototype sensors for process analysis. The firm plans to expand its diagnostics work and expects a clinical trial for a skin cancer diagnostic to commence in early 2024. Proxisense completed a 2023 funding round that exceeded its goal and will support further development of its sensor platforms. Proxisense is an Oxford University spinout supplying specialised proximity sensors and systems to measure contamination in critical fluid systems. Its proximity sensor technology utilises an eddy current sensor to enable very accurate measurement of component position in real time. The technology can measure the position of turbine blade tips and monitor blade vibration while systems are in use. Products have been developed for extreme and inaccessible environments. Proxisense provides comprehensive health-monitoring technology that allows users to detect degrading performance and the possible onset of component failure. The company has secured investment from the Parkwalk Opportunities Fund, as announced by Parkwalk Advisors. Proxisense is an Oxford University spinout that supplies specialised proximity sensors and systems designed to measure contamination in critical fluid systems. Its proximity sensor technology utilises an eddy current sensor to enable very accurate, real-time measurement of component positions. The sensors are developed for use in extreme and inaccessible environments. Use cases described include measuring the position of turbine blade tips and monitoring blade vibration while systems are in use. Proxisense positions this technology as comprehensive health‑monitoring, allowing users to detect degrading performance and the possible onset of component failure.

Total raised

$1M

Funding rounds

3

Latest round

Equity

Latest activity

Dec 2023